Zobrazeno 1 - 10
of 26
pro vyhledávání: '"qiuying shen"'
Autor:
Daizhuang Peng, Sumei Xu, Ting Zou, Yahui Wang, Wenjuan Ouyang, Yalan Zhang, Chengmei Dong, Dai Li, Jie Guo, Qiuying Shen, Xiaolei Hu, Wenzhi Zhou, Xiaomin Li, Qun Qin
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background AD16 is a Class 1.1 new drug candidate for Alzheimer’s disease (AD), which has demonstrated potential benefits in AD by reducing neuroinflammation in preclinical studies. Herein, the pharmacokinetics (PK), safety, and tolerabili
Externí odkaz:
https://doaj.org/article/358e8135b8854330bee03778f3c368aa
Autor:
Xi Chen, Zhijie Xu, Shuangshuang Zeng, Xiang Wang, Wanli Liu, Long Qian, Jie Wei, Xue Yang, Qiuying Shen, Zhicheng Gong, Yuanliang Yan
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Nafamostat mesylate (NM), a synthetic serine protease inhibitor first placed on the market by Japan Tobacco in 1986, has been approved to treat inflammatory-related diseases, such as pancreatitis. Recently, an increasing number of studies have highli
Externí odkaz:
https://doaj.org/article/7d41b5b2b7d64b7ea5328ac288e0946f
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47441 (2012)
Vulnerability for anxiety and depressive disorders is thought to have origins in early life and is increasingly recognized to involve deficits in GABAergic neurotransmission. Mice that were rendered heterozygous for the γ2 subunit gene of GABA(A) re
Externí odkaz:
https://doaj.org/article/cf7b0fe0c1fe4feb99455aa175b45c27
Publikováno v:
Computers, Materials & Continua. 75:197-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a5dbd9455bfe0b32583a54e57e06841
https://doi.org/10.32604/cmc.2023.036365
https://doi.org/10.32604/cmc.2023.036365
Aims: A phase I open-label study assessed the effect of multiple oral doses of a potent CYP3A4 inducer (rifampicin) on the pharmacokinetic profile of SHR2554, a novel enhancer of zeste homolog 2 inhibitor (EZH2) and CYP3A4 substrate. Methods: Eightee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44e3cc5ec53d4cbafc7c878eee057253
https://doi.org/10.22541/au.168322865.51461018/v1
https://doi.org/10.22541/au.168322865.51461018/v1
Autor:
Qiuying Shen, Wentao Zhang
Publikováno v:
Fourth International Conference on Optoelectronic Science and Materials (ICOSM 2022).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47a01d45cf780b5c3c6a6e1e75d79e36
https://doi.org/10.1117/12.2667297
https://doi.org/10.1117/12.2667297
Autor:
Qiuying Shen, Wentao Zhang
Publikováno v:
Proceedings of the 4th Management Science Informatization and Economic Innovation Development Conference, MSIEID 2022, December 9-11, 2022, Chongqing, China.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8553fb5d1489a365d6c7002e7422d85e
https://doi.org/10.4108/eai.9-12-2022.2327573
https://doi.org/10.4108/eai.9-12-2022.2327573
Publikováno v:
2022 4th International Academic Exchange Conference on Science and Technology Innovation (IAECST).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41fd42aa00c3f37f06b16c604ac7bfee
https://doi.org/10.1109/iaecst57965.2022.10062264
https://doi.org/10.1109/iaecst57965.2022.10062264
Autor:
youxuan Wu, xuefeng zhong, Xiaomin Li, Wanli Liu, Yanxin Zhang, qiuying shen, Sumei Xu, Pingsheng Xu
Aim: This study has been designed to assess the bioequivalence of the newly developed delayed-release oral tablets (test) 30 mg nifedipine compared to its marketed counterpart (30 mg; reference) in healthy adult Chinese volunteers. Methods: We conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ffa4f0c36f79b948da199cb271c3b6c
https://doi.org/10.22541/au.166944603.38385110/v1
https://doi.org/10.22541/au.166944603.38385110/v1
Autor:
Xue Yang, Wanli Liu, Xiang Wang, Yuanliang Yan, Long Qian, Shuangshuang Zeng, Zhijie Xu, Xi Chen, Jie Wei, Zhicheng Gong, Qiuying Shen
Publikováno v:
Cancer Biomarkers. 24:449-459
Objective Sirtuins (SIRT) are NAD+-dependent protein deacetylases that are involved in the regulation of cancer-associated pathways. However, the biological role of these deacetylases remains elusive in glioblastoma (GBM). Here, we evaluated the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d01827bfb4a4351c87bfe7c5e54c2fb
https://doi.org/10.3233/cbm-182197
https://doi.org/10.3233/cbm-182197